Literature DB >> 8503783

T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individuals.

R A Damhof1, J W Drijfhout, A J Scheffer, J B Wilterdink, G W Welling, S Welling-Wester.   

Abstract

To locate T cell determinants of glycoprotein D (gD) of herpes simplex virus type 1 (HSV-1), proliferation assays of lymphocytes obtained from 10 healthy HSV-seropositive individuals were performed using 34 overlapping gD peptides as antigens. Despite large differences between individual responses to the peptides both in number of stimulating peptides and gD regions, three regions (1-54, 110-214, and 290-314) induced a response in 50% or more of the HSV-seropositives. T cells were less frequently stimulated by peptides of region 210-294. No correlation was found between serological data and proliferative responses to the peptides. The diversity in T cell response to the peptides suggests a lack of immunodominance, implying that a single peptide/region of gD, or a combination of peptides, will not be sufficient to serve as a basis for a future HSV-1 vaccine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503783     DOI: 10.1007/BF01319007

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

Review 1.  B and T cell epitopes of glycoprotein D of herpes simplex virus type 1.

Authors:  S Welling-Webster; A J Scheffer; G W Welling
Journal:  FEMS Microbiol Immunol       Date:  1991-04

2.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.

Authors:  H J Geerligs; M Feijlbrief; M Bolk; C A Bos; J W Drijfhout; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 4.  The quest for a herpes simplex virus vaccine: background and recent developments.

Authors:  M J Hall; K Katrak
Journal:  Vaccine       Date:  1986-09       Impact factor: 3.641

5.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.

Authors:  L R Stanberry; D I Bernstein; R L Burke; C Pachl; M G Myers
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

7.  Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.

Authors:  H J Geerligs; C H Kocken; J W Drijfhout; W J Weijer; W Bloemhoff; J B Wilterdink; G W Welling; S Welling-Wester
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

8.  Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.

Authors:  S Krishna; B A Blacklaws; H A Overton; D H Bishop; A A Nash
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

9.  A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.

Authors:  E Watari; B Dietzschold; G Szokan; E Heber-Katz
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  Lack of immunodominance in the T cell response to herpes simplex virus glycoprotein D after administration of infectious virus.

Authors:  K Yamashita; E Heber-Katz
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  8 in total

1.  Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.

Authors:  Xiuli Zhang; Florence A Castelli; Xiaoming Zhu; Michele Wu; Bernard Maillère; Lbachir BenMohamed
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

2.  Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

Authors:  Lbachir BenMohamed; Georges Bertrand; Cory D McNamara; Helene Gras-Masse; Juergen Hammer; Steven L Wechsler; Anthony B Nesburn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Development of a nucleoprotein-based enzyme-linked immunosorbent assay using a synthetic peptide antigen for detection of avian metapneumovirus antibodies in Turkey sera.

Authors:  Rene Alvarez; M Kariuki Njenga; Melissa Scott; Bruce S Seal
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

4.  Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.

Authors:  Min Kim; Janette Taylor; John Sidney; Zorka Mikloska; Neil Bodsworth; Katerina Lagios; Heather Dunckley; Karen Byth-Wilson; Martine Denis; Robert Finlayson; Rajiv Khanna; Alessandro Sette; Anthony L Cunningham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 5.  J-LEAPS peptide and LEAPS dendritic cell vaccines.

Authors:  Ken S Rosenthal; Patricia Taylor; Daniel H Zimmerman
Journal:  Microb Biotechnol       Date:  2011-09-06       Impact factor: 5.813

6.  Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.

Authors:  Peter B Gilbert; Jean-Louis Excler; Georgia D Tomaras; Lindsay N Carpp; Barton F Haynes; Hua-Xin Liao; David C Montefiori; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Gustavo H Kijak; Sodsai Tovanabutra; Donald P Francis; Carter Lee; Faruk Sinangil; Phillip W Berman; Nakorn Premsri; Prayura Kunasol; Robert J O'Connell; Nelson L Michael; Merlin L Robb; Rhoda Morrow; Lawrence Corey; Jerome H Kim
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

7.  Predicting HLA CD4 Immunogenicity in Human Populations.

Authors:  Sandeep Kumar Dhanda; Edita Karosiene; Lindy Edwards; Alba Grifoni; Sinu Paul; Massimo Andreatta; Daniela Weiskopf; John Sidney; Morten Nielsen; Bjoern Peters; Alessandro Sette
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

8.  Frequent Recurrences of Genital Herpes Are Associated with Enhanced Systemic HSV-Specific T Cell Response.

Authors:  Michal Holub; Alžběta Stráníková; Pavel Chalupa; Simona Arientová; Kateřina Roubalová; Ondřej Beran
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-01-23       Impact factor: 2.471

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.